Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Celosia Therapeutics

Request full access

A privately held pre-clinical stage gene therapy company, developing solutions for neurodegenerative diseases that have limited alternative therapeutic options

Sydney, AustraliaFounded 2022Biotech & Life Sciences

About Celosia Therapeutics

Celosia Therapeutics is a pioneering biotech company focused on developing groundbreaking gene therapies to treat neurodegenerative diseases that currently lack effective therapeutic options. The company operates in the biotechnology and pharmaceutical market, primarily serving patients suffering from conditions such as ALS, MND, LGD disease, frontotemporal dementia, and Dravet Syndrome. Celosia Therapeutics leverages advances in gene therapy and a deeper understanding of molecular pathways to modify the neuronal microenvironment, aiming to significantly improve patient outcomes.

The business model of Celosia Therapeutics involves extensive research and development (R&D) to create innovative treatments, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the commercialization of these therapies, partnerships with pharmaceutical companies, and potential licensing agreements.

Celosia Therapeutics' team comprises scientists, clinicians, innovators, and entrepreneurs dedicated to redefining the treatment landscape for individuals with devastating neurodegenerative diseases. The company's mission is to change lives forever by providing new hope and effective solutions for patients and their families.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2022
Headquarters
Sydney, Australia
Employees
6
Open positions
None listed
Dealroom signal
69.9/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Spinout, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Nov 2024 $11M $43M Iomar Barrett · UniSuper · Uniseed Ventures ↗
SEEDOther financing Nov 2022 $2M $8M Undisclosed ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Celosia Therapeutics website traffic

Latest recorded traffic for Celosia Therapeutics is 450 monthly website visits, down 27.4% over the last three months. Celosia Therapeutics's team grew 20% over the past year.

Latest monthly visits450 3-month web change-27.4% 1-year team growth+20%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Celosia Therapeutics in the Sydney ecosystem

Live from Dealroom

The Celosia Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Uniseed Ventures
  • Iomar Barrett
  • UniSuper

Other known investors1 additional known investor

  • Macquarie University
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇦🇺 Australia100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Celosia Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Celosia Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.